Azacitidine and Eltrombopag drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azacitidine (azacitidine) and Eltrombopag (eltrombopag). Common drug interactions include febrile neutropenia among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Azacitidine and Eltrombopag. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Azacitidine?

Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 17,184 Azacitidine users. Check the latest studies of Azacitidine.

What is Eltrombopag?

Eltrombopag has active ingredients of eltrombopag. eHealthMe is studying from 233 Eltrombopag users. Check the latest studies of Eltrombopag.

On Jul, 13, 2026

43 people who take Azacitidine and Eltrombopag together, and have interactions are studied.

Azacitidine and Eltrombopag drug interactions.

What are the common drug interactions of Azacitidine and Eltrombopag, by gender? *:

female:

Febrile neutropenia (fever with reduced white blood cells)
Lower respiratory tract infection
Pyrexia (fever)
Acute respiratory failure
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Anaemia (lack of blood)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Malignant neoplasm progression (cancer tumour came back)
General physical health deterioration (weak health status)

male:

Febrile neutropenia (fever with reduced white blood cells)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Respiratory failure (inadequate gas exchange by the respiratory system)
Septic shock (shock due to blood infection)
Tumour associated fever (fever because of tumour)
Anaemia (lack of blood)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Epistaxis (bleed from the nose)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Angina pectoris (chest pain due to ischemia of the heart muscle)

What are the common drug interactions of Azacitidine and Eltrombopag, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Neoplasm (tumour)
Febrile neutropenia (fever with reduced white blood cells)

50-59:

Febrile neutropenia (fever with reduced white blood cells)
Acute respiratory failure
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Septic shock (shock due to blood infection)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Malignant neoplasm progression (cancer tumour came back)

60+:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Pyrexia (fever)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Respiratory failure (inadequate gas exchange by the respiratory system)
Tumour associated fever (fever because of tumour)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Epistaxis (bleed from the nose)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Septic shock (shock due to blood infection)
Angina pectoris (chest pain due to ischemia of the heart muscle)

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 34 people, 79.07%
Thrombocytopenia (decrease of platelets in blood): 23 people, 53.49%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 9 people, 20.93%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Azacitidine and Eltrombopag?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously